IKENA ONCOLOGY INC

IKNA10 Dec 2024
Healthcare
$1.67
-0.01 (-0.60%)
Lowest Today
$1.62
Highest Today
$1.69
Today’s Open
$1.67
Prev. Close
$1.68
52 Week High
$2.32
52 Week Low
$1.22
To Invest in IKENA ONCOLOGY INC

IKENA ONCOLOGY INC

Healthcare
IKNA10 Dec 2024
-0.01 (-0.60%)
1M
3M
6M
1Y
5Y
Low
$1.62
Day’s Range
High
$1.69
1.62
52 Week Low
$1.22
52-Week Range
52 Week High
$2.32
1.22
1 Day
-
1 Week
-1.77%
1 month return
-6.21%
3 month return
-2.35%
6 month return
-5.14%
1 Year return
-13.08%
3 Years return
-88.29%
5 Years return
-
10 Years return
-
Institutional Holdings
Bvf Inc
9.88
Blue Owl Capital Holdings LP
8.48
Orbimed Advisors, LLC
7.33
Omega Fund Management LLC
4.66
Worldwide Healthcare Ord
3.37
Vanguard Group Inc
2.87
Vanguard Total Stock Mkt Idx Inv
2.18

Market Status

Fundamentals
Market Cap
81.07 mln
PB Ratio
0.6
PE Ratio
0
Enterprise Value
-48.57 mln
Total Assets
192.09 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Ikena Oncology, Inc. operates as an oncology company that develops differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the United States. Its lead program is IK-930, an internally discovered, oral, TEAD1-selective, small molecule inhibitor of the Hippo pathway. The company also develops IK-595, a molecular glue designed to trap MEK and RAF in an inactive complex. Ikena Oncology, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Organisation
IKENA ONCOLOGY INC
Employees
14
Industry
Biotechnology
CEO
Dr. Mark  Manfredi Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step